Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia

Background Recent studies suggest that sustained use of generic antibiotics may be associated with clinical failure and emergence of antibacterial resistance. The present study was designed to determine the clinical outcome between the use of generic meropenem (GM) and brand-name meropenem (BNM). Ad...

Full description

Autores:
Ordóñez, Karen
Feinstein, Max M.
Reyes, Sergio
Hernández Gómez, Cristhian
Pallares, Christian José
Villegas, María Virginia
Tipo de recurso:
Fecha de publicación:
2019
Institución:
Universidad El Bosque
Repositorio:
Repositorio U. El Bosque
Idioma:
eng
OAI Identifier:
oai:repositorio.unbosque.edu.co:20.500.12495/1699
Acceso en línea:
http://hdl.handle.net/20.500.12495/1699
https://doi.org/10.1016/j.bjid.2019.06.010
Palabra clave:
Costos de los medicamentos
Cuidados críticos
Bacterias
Generic drugs
Meropenem
Mortality
Rights
License
Attribution-NonCommercial-NoDerivatives 4.0 International